With his success in several key management positions within Roche Diagnostics, Dr. Schinecker brings the required organizational and operating skills to 454 Life Sciences’ highly innovative and ...

Roche and CuraGen have announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in ...

Roche Diagnostics (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY) and Takara Bio (TSE Mothers: 4974), the Shiga (Japan)-based supplier of systems for use in life science research, announced that they have ...

"The proposed acquisition will strengthen Roche's current offering in the Life Science market by providing complementary solutions to our current portfolio. Our ability to offer a total solution ...

As reported earlier, the LightCycler® Nano Real-Time PCR System is the product of an exclusive OEM agreement with IT-IS Life Sciences Ltd (UK and Ireland), using proprietary Roche dyes and ...

Roche remains committed to life-science business. Roche today announced changes to the management and set-up of its life-science business. The Applied Science Business Area will be dissolved and ...